Apollomics (APLM) Payables (2021 - 2025)
Apollomics' (APLM) quarterly Payables came in at $124000.0 in Q4 2025, up 21.57% year-over-year from $102000.0 in Q4 2024, and down 74.49% quarter-over-quarter from $486000.0 in Q2 2025.
Analysis
Apollomics (APLM) Payables (2021 - 2025) Analysis & Trends
Apollomics (APLM) has reported Payables for 5 consecutive years, with $124000.0 the latest figure, recorded in Q4 2025.
- On a quarterly basis, Payables rose 21.57% year-over-year to $124000.0 in Q4 2025; TTM through Dec 2025 was $124000.0, a 21.57% increase from a year earlier, with the FY2025 full-year figure at $124000.0, up 21.57% from the prior year.
- Payables was $124000.0 for Q4 2025 at Apollomics, down from $486000.0 in the prior quarter.
- Over five years, Payables peaked at $125.6 million in Q4 2021 and troughed at $102000.0 in Q4 2024.
- A 5-year average of $36.9 million and a median of $716500.0 in 2023 frame the typical range for Payables.
- Across the five-year window, Payables declined 24.86% in 2022 and gained 21.57% in 2025, its largest moves.
- Over 5 years, Payables stood at $125.6 million in 2021, then dropped by 24.86% to $94.4 million in 2022, then sank by 99.0% to $947000.0 in 2023, then sank by 89.23% to $102000.0 in 2024, then increased by 21.57% to $124000.0 in 2025.
- The last three Payables figures came in at $124000.0 (Q4 2025), $486000.0 (Q2 2025), and $102000.0 (Q4 2024), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 206.44 Bn | 192.45 Bn | 7.24 Bn | 2.87 Bn |
| 2 | Gilead Sciences | 179.97 Bn | 176.79 Bn | 6.22 Bn | 674.00 Mn |
| 3 | Vertex Pharmaceuticals | 130.57 Bn | 122.72 Bn | 2.84 Bn | 429.50 Mn |
| 4 | Regeneron Pharmaceuticals | 81.63 Bn | 73.63 Bn | 3.93 Bn | 1.16 Bn |
| 5 | Argenx Se | 60.34 Bn | 55.16 Bn | 1.37 Bn | 1.52 Bn |
| 6 | Moderna | 54.37 Bn | 49.23 Bn | 52.00 Mn | 167.00 Mn |
| 7 | Alnylam Pharmaceuticals | 33.07 Bn | 29.76 Bn | 992.69 Mn | 108.02 Mn |
| 8 | Biogen | 31.84 Bn | 30.55 Bn | 1.96 Bn | 403.90 Mn |
| 9 | Roivant Sciences | 29.49 Bn | 29.49 Bn | 1.16 Mn | 25.08 Mn |
| 10 | Apollomics | 34.50 Mn | 31.23 Mn | - | 124,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 124,000.00 |
| Jun 30, 2025 | 486,000.00 |
| Dec 31, 2024 | 102,000.00 |
| Jun 30, 2023 | 947,000.00 |
| Dec 31, 2022 | 94.35 Mn |
| Dec 31, 2021 | 125.56 Mn |